{"id":1385294,"title":"DSEN Abstract: Exposure to valsartan products with nitrosamine impurities in the US, Canada, and Denmark - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-24","captureTimestamp":"2026-03-24T04:31:00.510000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53927.html?wbdisable=false","snippet":"DSEN Abstract Exposure to valsartan products with nitrosamine impurities in the US, Canada, and Denmark A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) Our findings suggest that many patients received valsartan products with nitrosamine…","rawSnapshotUrl":"/api/snapshots/raw/1385294","browseUrl":"https://replay.healtharchive.ca/job-8/20260324043100/https://cihr-irsc.gc.ca/e/53927.html?wbdisable=false#ha_snapshot=1385294","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}